Component BBH (mg) MCC (mg) PVPP (mg) Lactose (mg) Hydrated mannitol (mg) Mannitol (mg) Correctives (mg) DT in the new apparatus (s) DT in disintegration apparatus (s) DT in oral cavity (s)
F1 10 80 10 100 0 0 10 53 ± 2 13 ± 1 62 ± 8
F2 10 80 10 0 100 0 10 90 ± 3 24 ± 2 110 ± 10
F3 10 180 10 0 0 0 10 >120 38 ± 3 >120
F4 10 80 10 0 0 100 10 70 ± 3 12 ± 2 83 ± 9
F5 10 0 10 180     10 >120 40 ± 3 >120
F6 10 60 10 120     10 65 ± 3 28 ± 2 82 ± 9
F7 10 100 10 80     10 50 ± 2 10 ± 1 62 ± 8
F8 10 80 8 102     10 65 ± 3 20 ± 2 77 ± 10
F9 10 80 0 110     10 >120 37 ± 2 >120
F10 10 80 12 98     10 45 ± 2 14 ± 2 60 ± 9
F11 10 80 8 inside, 2 outside 100     10 48 ± 2 13 ± 1 58 ± 9
F12 10 80 0 100     10 >120 43 ± 4 >120
Table 1: The formulations of orally disintegrating tablets of BBH.